These findings are supported by a study [34] showing that hospitalized COVID-19 patients have elevated TNF-α concentrations during hospital admission, and that these are associated with organ damage and worse COVID-19-related outcomes, thus explaining the improved outcome with TNF-α blockade. Here, TNF is linked to COVID-19.